Bachar Samra
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Autoimmune and Inflammatory Disorders Research
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- Neutropenia and Cancer Infections 3
- COVID-19 and healthcare impacts 2
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Hagop M. Kantarjian (6 shared papers)Nicholas J. Short (4 shared papers)Elias Jabbour (4 shared papers)Farhad Ravandi (4 shared papers)Marina Konopleva (4 shared papers)Naval Daver (3 shared papers)Courtney D. DiNardo (3 shared papers)Alessandro Isidori (1 shared paper)
- Journals
- Blood (3 papers)Frontiers in Oncology (2 papers)Hematological Oncology (1 paper)Journal of Hematology & Oncology (1 paper)Acta Haematologica (1 paper)
- Partner nations
- United StatesLebanonFrance
In The Last Decade
Bachar Samra
18 papers receiving 381 citations
Peers
Comparison fields: 5 of 57
- Hematology 145
- Oncology 116
- Public Health, Environmental and Occupational Health 101
- Genetics 29
- Pathology and Forensic Medicine 36
Countries citing papers authored by Bachar Samra
This map shows the geographic impact of Bachar Samra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bachar Samra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bachar Samra more than expected).
Fields of papers citing papers by Bachar Samra
This network shows the impact of papers produced by Bachar Samra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bachar Samra. The network helps show where Bachar Samra may publish in the future.
Co-authors
The 25 scholars most cited alongside Bachar Samra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 118 | |
| 2 | 2020 | 52 | |
| 3 | 2021 | 44 | |
| 4 | 2016 | 33 | |
| 5 | 2015 | 29 | |
| 6 | 2018 | 27 | |
| 7 | 2020 | 17 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 12 | |
| 10 | 2017 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2020 | 3 | |
| 16 | 2019 | 3 | |
| 17 | 2018 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2020 | 0 |
About Bachar Samra
Bachar Samra is a scholar working on Oncology, Hematology, Public Health, Environmental and Occupational Health, Immunology and Genetics, having authored 19 papers that have together received 385 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Neutropenia and Cancer Infections (3 papers), T-cell and Retrovirus Studies (2 papers), Immune Cell Function and Interaction (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Hematology (145 citations), Oncology (116 citations), Public Health, Environmental and Occupational Health (101 citations), Genetics (29 citations) and Pathology and Forensic Medicine (36 citations). Bachar Samra has collaborated with scholars based in United States, Lebanon and France. Frequent co-authors include Hagop M. Kantarjian, Nicholas J. Short, Elias Jabbour, Farhad Ravandi, Marina Konopleva, Naval Daver, Courtney D. DiNardo, Alessandro Isidori, Babak Baseri and Eric Tam. Their work appears in journals such as Blood, Frontiers in Oncology, Hematological Oncology, Journal of Hematology & Oncology and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.